Cargando…
LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA)
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506361/ http://dx.doi.org/10.1016/j.annonc.2020.08.2321 |
| _version_ | 1783585000798552064 |
|---|---|
| author | Joerger, M. Metaxas, Y. Schmitt, A. Koeberle, D. Zaman, K. Betticher, D. Mach, N. Renner, C. Mark, M.T. Petrausch, U. Caspar, C.B. Britschgi, C. Taverna, C. Zenger, F. Mingrone, W. Schulz, J. Kopp, C. Hayoz, S. Stathis, A. von Moos, R. |
| author_facet | Joerger, M. Metaxas, Y. Schmitt, A. Koeberle, D. Zaman, K. Betticher, D. Mach, N. Renner, C. Mark, M.T. Petrausch, U. Caspar, C.B. Britschgi, C. Taverna, C. Zenger, F. Mingrone, W. Schulz, J. Kopp, C. Hayoz, S. Stathis, A. von Moos, R. |
| author_sort | Joerger, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506361 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75063612020-09-23 LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) Joerger, M. Metaxas, Y. Schmitt, A. Koeberle, D. Zaman, K. Betticher, D. Mach, N. Renner, C. Mark, M.T. Petrausch, U. Caspar, C.B. Britschgi, C. Taverna, C. Zenger, F. Mingrone, W. Schulz, J. Kopp, C. Hayoz, S. Stathis, A. von Moos, R. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506361/ http://dx.doi.org/10.1016/j.annonc.2020.08.2321 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Joerger, M. Metaxas, Y. Schmitt, A. Koeberle, D. Zaman, K. Betticher, D. Mach, N. Renner, C. Mark, M.T. Petrausch, U. Caspar, C.B. Britschgi, C. Taverna, C. Zenger, F. Mingrone, W. Schulz, J. Kopp, C. Hayoz, S. Stathis, A. von Moos, R. LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) |
| title | LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) |
| title_full | LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) |
| title_fullStr | LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) |
| title_full_unstemmed | LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) |
| title_short | LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA) |
| title_sort | lba80 outcome and prognostic factors of sars cov-2 infection in cancer patients: a cross-sectional study (sakk 80/20 casa) |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506361/ http://dx.doi.org/10.1016/j.annonc.2020.08.2321 |
| work_keys_str_mv | AT joergerm lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT metaxasy lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT schmitta lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT koeberled lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT zamank lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT betticherd lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT machn lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT rennerc lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT markmt lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT petrauschu lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT casparcb lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT britschgic lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT tavernac lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT zengerf lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT mingronew lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT schulzj lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT koppc lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT hayozs lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT stathisa lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa AT vonmoosr lba80outcomeandprognosticfactorsofsarscov2infectionincancerpatientsacrosssectionalstudysakk8020casa |